Frequent MED12 mutations in phyllodes tumours of the breast

by Yoshida, M, Sekine, S, Ogawa, R, Yoshida, H, Maeshima, A, Kanai, Y, Kinoshita, T, Ochiai, A
Published 2015

Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer

by Mitsunaga, S, Ikeda, M, Shimizu, S, Ohno, I, Furuse, J, Inagaki, M, Higashi, S, Kato, H, Terao, K, Ochiai, A
Published 2013

KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab

by Bando, H, Yoshino, T, Tsuchihara, K, Ogasawara, N, Fuse, N, Kojima, T, Tahara, M, Kojima, M, Kaneko, K, Doi, T, Ochiai, A, Esumi, H, Ohtsu, A
Published 2011

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer

by Kawamoto, Y, Tsuchihara, K, Yoshino, T, Ogasawara, N, Kojima, M, Takahashi, M, Ochiai, A, Bando, H, Fuse, N, Tahara, M, Doi, T, Esumi, H, Komatsu, Y, Ohtsu, A
Published 2012